In a study by Stokes et al., pancreatic tumors from animals treated with PF-562,271 (VS-6063, [defactinib] a small molecule inhibitor of FAK) led to a significant decrease in the number CAFs and a significant decrease in tumor cell proliferation [96]. Here, PTK2 is linked to pancreatic neoplasm.